Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue

Journal of Clinical Investigation

Volumn 127, Issue 4, 2017, Pages 1375-1391

  Vallabhajosyula, Prashanth ^a   Korutla, Laxminarayana ^a   Habertheuer, Andreas ^a   Yu, Ming ^a   Rostami, Susan ^a   Yuan, Chao Xing ^b   Reddy, Sanjana ^a   Liu, Chengyang ^a   Korutla, Varun ^a   Koeberlein, Brigitte ^a   Trofe Clark, Jennifer ^a   Rickels, Michael R ^c,d   Naji, Ali ^a,d  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b Proteomics and Systems Biology Core   (United States)

^c Department of Medicine   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CD3 ANTIBODY; FXYD2 PROTEIN; GLUCAGON; GLUCOSE; HLA ANTIBODY; INSULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; MICRORNA; MICRORNA 122 5P; MICRORNA 1281; MICRORNA 16-5P; MICRORNA 191 5P; MICRORNA 23 3P; MICRORNA 24 3P; MICRORNA 3613 3P; MICRORNA 3613 5P; MICRORNA 375; MICRORNA 4508; MICRORNA 4668 5P; MICRORNA 486 5P; MICRORNA 5787; MICRORNA 6732 5P; MICRORNA 7704; MICRORNA 8075; PROTEIN; RIBOSOME RNA; SOMATOSTATIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; PROTEOME;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; EXOSOME; FOLLOW UP; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; IMMUNOLOGICAL MONITORING; KIDNEY TRANSPLANTATION; KIDNEY TUBULE CELL; LONG TERM CARE; MOUSE; NONHUMAN; ORGAN DONOR; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEOMICS; TISSUE SPECIFICITY; XENOTRANSPLANTATION; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; DIABETES MELLITUS, TYPE 1; IMMUNOLOGY; METABOLISM; NUDE MOUSE;

ANIMALS; BIOMARKERS; DIABETES MELLITUS, TYPE 1; EXOSOMES; GRAFT REJECTION; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY TRANSPLANTATION; MICE, NUDE; MICRORNAS; ORGAN SPECIFICITY; PROTEOME;

EID: 85018697833     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI87993     Document Type: Article

References (59)

1. Yusen RD, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report-2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant. 2015;34(10):1264-1277.
2. Lund LH, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report-2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant. 2015;34(10):1244-1254.
3. Goldfarb SB, et al. The Registry of the International Society for Heart and Lung Transplantation: Eighteenth Official Pediatric Lung and Heart-Lung Transplantation Report-2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant. 2015;34(10):1255-1263.
4. Dipchand AI, et al. The Registry of the International Society for Heart and Lung Transplantation: Eighteenth Official Pediatric Heart Transplantation Report-2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant. 2015;34(10):1233-1243.
5. Josephson MA. Monitoring and managing graft health in the kidney transplant recipient. Clin J Am Soc Nephrol. 2011;6(7):1774-1780.
6. Farid WR, et al. Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation. Liver Transpl. 2012;18(3):290-297.
7. Fleissner F, Goerzig Y, Haverich A, Thum T. Microvesicles as novel biomarkers and therapeutic targets in transplantation medicine. Am J Transplant. 2012;12(2):289-297.
8. Johann DJ Jr. Blonder J. Biomarker discovery: tissues versus fluids versus both. Expert Rev Mol Diagn. 2007;7(5):473-475.
9. Julich H, Willms A, Lukacs-Kornek V, Kornek M. Extracellular vesicle profiling and their use as potential disease specific biomarker. Front Immunol. 2014;5:413.
10. Lakkaraju A, Rodriguez-Boulan E. Itinerant exosomes: emerging roles in cell and tissue polarity. Trends Cell Biol. 2008;18(5):199-209.
11. Lo DJ, Kaplan B, Kirk AD. Biomarkers for kidney transplant rejection. Nat Rev Nephrol. 2014;10(4):215-225.
12. Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 2010;73(10):1907-1920.
13. Matsumoto S, et al. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ Res. 2013;113(3):322-326.
14. Roedder S, Vitalone M, Khatri P, Sarwal MM. Biomarkers in solid organ transplantation: establishing personalized transplantation medicine. Genome Med. 2011;3(6):37.
15. Shan J, et al. MicroRNAs: potential biomarker in organ transplantation. Transpl Immunol. 2011;24(4):210-215.
16. Turchinovich A, Samatov TR, Tonevitsky AG, Burwinkel B. Circulating miRNAs: cell-cell communication function? Front Genet. 2013;4:119.
17. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654-659.
18. Lötvall J, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles. 2014;3:26913.
19. Arystarkhova E, et al. Hyperplasia of pancreatic beta cells and improved glucose tolerance in mice deficient in the FXYD2 subunit of Na,KATPase. J Biol Chem. 2013;288(10):7077-7085.
20. Flamez D, et al. A genomic-based approach identifies FXYD domain containing ion transport regulator 2 (FXYD2)gammaa as a pancreatic beta cell-specific biomarker. Diabetologia. 2010;53(7):1372-1383.
21. Hald J, et al. Pancreatic islet and progenitor cell surface markers with cell sorting potential. Diabetologia. 2012;55(1):154-165.
22. Wang F, et al. FXYD2, a ? subunit of Na+, K+-ATPase, maintains persistent mechanical allodynia induced by inflammation. Cell Res. 2015;25(3):318-334.
23. Poy MN, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 2004;432(7014):226-230.
24. Poy MN, et al. miR-375 maintains normal pancreatic alpha-and beta-cell mass. Proc Natl Acad Sci U S A. 2009;106(14):5813-5818.
25. Hsu SH, et al. Essential metabolic, antiinflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest. 2012;122(8):2871-2883.
26. Jopling C. Liver-specific microRNA-122: Biogenesis and function. RNA Biol. 2012;9(2):137-142.
27. Lewis AP, Jopling CL. Regulation and biological function of the liver-specific miR-122. Biochem Soc Trans. 2010;38(6):1553-1557.
28. Thakral S, Ghoshal K. miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir. Curr Gene Ther. 2015;15(2):142-150.
29. Tsai WC, et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest. 2012;122(8):2884-2897.
30. Wang K, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A. 2009;106(11):4402-4407.
31. Rickels MR, Kamoun M, Kearns J, Markmann JF, Naji A. Evidence for allograft rejection in an islet transplant recipient and effect on beta-cell secretory capacity. J Clin Endocrinol Metab. 2007;92(7):2410-2414.
32. Aquino-Dias EC, et al. Non-invasive diagnosis of acute rejection in kidney transplants with delayed graft function. Kidney Int. 2008;73(7):877-884.
33. Kotsch K, et al. Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection. Transplantation. 2004;77(12):1866-1875.
34. Li B, et al. Noninvasive diagnosis of renalallograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med. 2001;344(13):947-954.
35. Suthanthiran M, et al. Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med. 2013;369(1):20-31.
36. Tatapudi RR, et al. Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int. 2004;65(6):2390-2397.
37. Su D, et al. Angiopoietin-1 production in islets improves islet engraftment and protects islets from cytokine-induced apoptosis. Diabetes. 2007;56(9):2274-2283.
38. Pratt JR, Basheer SA, Sacks SH. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med. 2002;8(6):582-587.
39. Xu M, et al. Expression of hemopexin in acute rejection of rat liver allograft identified by serum proteomic analysis. Shock. 2014;42(1):65-74.
40. Krikken JA, et al. High plasma hemopexin activity is an independent risk factor for late graft failure in renal transplant recipients. Transpl Int. 2010;23(8):805-812.
41. Deng MC, et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant. 2006;6(1):150-160.
42. Gielis EM, et al. Cell-free DNA: An upcoming biomarker in transplantation. Am J Transplant. 2015;15(10):2541-2551.
43. Gregson AL, et al. Altered exosomal RNA profiles in bronchoalveolar lavage from lung transplants with acute rejection. Am J Respir Crit Care Med. 2015;192(12):1490-1503.
44. Snyder TM, Khush KK, Valantine HA, Quake SR. Universal noninvasive detection of solid organ transplant rejection. Proc Natl Acad Sci U S A. 2011;108(15):6229-6234.
45. García Moreira V, Prieto García B, Baltar Martín JM, Ortega Suárez F, Alvarez FV. Cell-free DNA as a noninvasive acute rejection marker in renal transplantation. Clin Chem. 2009;55(11):1958-1966.
46. Macher HC, et al. Monitoring of transplanted liver health by quantification of organ-specific genomic marker in circulating DNA from receptor. PLoS One. 2014;9(12):e113987.
47. Sigdel TK, et al. A rapid noninvasive assay for the detection of renal transplant injury. Transplantation. 2013;96(1):97-101.
48. Zhang J, et al. Presence of donor-and recipient-derived DNA in cell-free urine samples of renal transplantation recipients: urinary DNA chimerism. Clin Chem. 1999;45(10):1741-1746.
49. Beck J, et al. Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury. Clin Chem. 2013;59(12):1732-1741.
50. Botezatu I, et al. Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin Chem. 2000;46(8 Pt 1):1078-1084.
51. De Vlaminck I, et al. Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci Transl Med. 2014;6(241):241ra77.
52. Thakur BK, et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 2014;24(6):766-769.
53. Zhang L, et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature. 2015;527(7576):100-104.
54. Ho TH, Charlet-BN, Poulos MG, Singh G, Swanson MS, Cooper TA. Muscleblind proteins regulate alternative splicing. EMBO J. 2004;23(15):3103-3112.
55. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A. 2004;101(36):13368-13373.
56. Rood IM, et al. Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome. Kidney Int. 2010;78(8):810-816.
57. Dragovic RA, et al. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine. 2011;7(6):780-788.
58. Gardiner C, Ferreira YJ, Dragovic RA, Redman CW, Sargent IL. Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis. J Extracell Vesicles. 2013;2:10.3402/jev.v2i0.19671.
59. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837-845.